Results 141 to 150 of about 3,514 (179)

Plaat1 deficiency reduces cardiac cardiolipin content and impairs exercise tolerance. [PDF]

J Lipid Res
Hashemi A, Liu MR, Chan JZ, Berdeklis AN, Cocco AD, Tomczewski MV, Strathdee D, Stark KD, Duncan RE.   +8 more
europepmc   +1 more source

Cranial, Renal, and Skeletal Anomalies in a Fetus With a Pathogenic Variant in the TAFAZZIN Gene. [PDF]

Prenat Diagn
Muir CR, Gilmore KL, Singh S, Vora NL.
europepmc   +1 more source

What can ATP content tell us about Barth syndrome muscle phenotypes? [PDF]

J Transl Genet Genom
Brault JJ, Conway SJ.
europepmc   +1 more source

ABHD18 degrades cardiolipin by stepwise hydrolysis of fatty acids. [PDF]

J Biol Chem
Ren M, Chen S, Greenberg ML, Schlame M.
europepmc   +1 more source

Cardiomiopatia dilatada idiopática [PDF]

, 2014
Lino Manuel Moreira Azevedo
core  

3D bioprinted myocardium patches for rare Barth syndrome: TAZ mutation correction in cardioblasts. [PDF]

Ann Med Surg (Lond)
Tahir A, Imtiaz E, Mahato RK.
europepmc   +1 more source

Cardiolipin and mitochondrial membrane integrity in neurodegeneration: insights from α-synuclein-driven Parkinson's disease. [PDF]

Acta Neuropathol Commun
Ruiz-Ortega ED, Wilkaniec A, Juárez J, Adamczyk A.   +3 more
europepmc   +1 more source

Analysis of neuronal cardiolipin and monolysocardiolipin from biological samples with cyclic ion mobility mass spectrometry. [PDF]

Front Physiol
Emaus KJ, Dunbar CA, Caruso J, Ruotolo BT, Wider JM, Sanderson TH.   +5 more
europepmc   +1 more source

Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth syndrome. [PDF]

Hum Mol Genet
Sniezek Carney O, Harris KW, Wohlfarter Y, Lee K, Butschek G, Anzmann AF, Hamacher-Brady A, Keller MA, Vernon HJ.   +8 more
europepmc   +1 more source

Plasmalogens as biomarkers and therapeutic targets. [PDF]

J Lipid Res
Curran CS, Remaley AT, Torabi-Parizi P.
europepmc   +1 more source